HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/1/E9    most recent 00184.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by DiCostanzo, C. A. Articles by Cherrington, A. D. Search for Related Content PubMed PubMed Citation Articles by DiCostanzo, C. A. Articles by Cherrington, A. D.

Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal

Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee

Submitted 28 April 2005 ; accepted in final form 12 August 2005

Portal glucose delivery enhances net hepatic glucose uptake (NHGU) relative to peripheral glucose delivery. We hypothesize that the sympathetic nervous system normally restrains NHGU, and portal glucose delivery relieves the inhibition. Two groups of 42-h-fasted conscious dogs were studied using arteriovenous difference techniques. Denervated dogs (DEN; n = 10) underwent selective sympathetic denervation by cutting the nerves at the celiac nerve bundle near the common hepatic artery; control dogs (CON; n = 10) underwent a sham procedure. After a 140-min basal period, somatostatin was given along with basal intraportal infusions of insulin and glucagon. Glucose was infused peripherally to double the hepatic glucose load (HGL) for 90 min (P1). In P2, glucose was infused intraportally (3–4 mg·kg^–1·min^–1), and the peripheral glucose infusion was reduced to maintain the HGL for 90 min. This was followed by 90 min (P3) in which portal glucose infusion was terminated and peripheral glucose infusion was increased to maintain the HGL. P1 and P3 were averaged as the peripheral glucose infusion period (PE). The average HGLs (mg·kg^–1·min^–1) in CON and DEN were 55 ± 3 and 54 ± 4 in the peripheral periods and 55 ± 3 and 55 ± 4 in P2, respectively. The arterial insulin and glucagon levels remained basal in both groups. NHGU (mg·kg^–1·min^–1) in CON averaged 1.7 ± 0.3 during PE and increased to 2.9 ± 0.3 during P2. NHGU (mg·kg^–1·min^–1) was greater in DEN than CON (P < 0.05) during PE (2.9 ± 0.4) and failed to increase significantly (3.2 ± 0.2) during P2 (not significant vs. CON). Selective sympathetic denervation increased NHGU during hyperglycemia but significantly blunted the response to portal glucose delivery.

autonomic nervous system; liver; canine

This article has been cited by other articles:

				M. Nishizawa, M. Shiota, M. C. Moore, S. M. Gustavson, D. W. Neal, and A. D. Cherrington Intraportal administration of neuropeptide Y and hepatic glucose metabolism Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1197 - R1204. [Abstract] [Full Text] [PDF]

				Z. An, C. A. DiCostanzo, M. C. Moore, D. S. Edgerton, D. P. Dardevet, D. W. Neal, and A. D. Cherrington Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E300 - E306. [Abstract] [Full Text] [PDF]